Creative Planning purchased a new position in shares of USANA Health Sciences, Inc. (NYSE:USNA) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,960 shares of the company’s stock, valued at approximately $219,000.
Several other hedge funds have also recently bought and sold shares of the company. Cubist Systematic Strategies LLC bought a new position in USANA Health Sciences in the 3rd quarter worth about $189,000. Hikari Power Ltd bought a new position in USANA Health Sciences in the 4th quarter worth about $255,000. Legal & General Group Plc boosted its stake in USANA Health Sciences by 7.6% in the 2nd quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock worth $259,000 after purchasing an additional 284 shares during the period. Trust Co. of Vermont boosted its stake in USANA Health Sciences by 482.7% in the 3rd quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock worth $272,000 after purchasing an additional 3,900 shares during the period. Finally, Voya Investment Management LLC boosted its stake in USANA Health Sciences by 13.4% in the 2nd quarter. Voya Investment Management LLC now owns 5,712 shares of the company’s stock worth $366,000 after purchasing an additional 676 shares during the period. Institutional investors own 44.67% of the company’s stock.
Several research analysts have commented on USNA shares. BidaskClub upgraded USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Thursday, October 26th. Sidoti downgraded USANA Health Sciences from a “buy” rating to a “neutral” rating in a research note on Wednesday, January 24th. TheStreet downgraded USANA Health Sciences from a “b+” rating to a “c+” rating in a research note on Tuesday, February 6th. Finally, Pivotal Research raised their target price on USANA Health Sciences from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Wednesday, February 7th.
Shares of USANA Health Sciences, Inc. (NYSE USNA) traded up $0.10 during midday trading on Wednesday, reaching $75.65. The company’s stock had a trading volume of 45,475 shares, compared to its average volume of 90,219. USANA Health Sciences, Inc. has a fifty-two week low of $52.55 and a fifty-two week high of $79.00. The company has a market cap of $1,811.44, a P/E ratio of 18.78 and a beta of 0.99.
USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.11 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.11. USANA Health Sciences had a return on equity of 27.02% and a net margin of 5.97%. The firm had revenue of $273.11 million for the quarter, compared to analysts’ expectations of $258.67 million. During the same quarter last year, the firm posted $0.87 EPS. The company’s revenue was up 8.0% compared to the same quarter last year. sell-side analysts predict that USANA Health Sciences, Inc. will post 4.25 EPS for the current fiscal year.
In other USANA Health Sciences news, Director Myron W. Wentz sold 164,916 shares of the firm’s stock in a transaction dated Tuesday, November 21st. The stock was sold at an average price of $66.40, for a total value of $10,950,422.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Global Ltd Gull sold 1,984 shares of the firm’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $74.78, for a total value of $148,363.52. Following the completion of the sale, the insider now directly owns 11,641,846 shares in the company, valued at approximately $870,577,243.88. The disclosure for this sale can be found here. In the last ninety days, insiders sold 449,703 shares of company stock worth $30,442,397. Insiders own 53.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Creative Planning Acquires Shares of 2,960 USANA Health Sciences, Inc. (NYSE:USNA)” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/14/creative-planning-takes-position-in-usana-health-sciences-inc-usna.html.
USANA Health Sciences Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.